Lexogen
PrivateLast Round
Grant
Apr 29, 2020
Total Funding Raised
$13,000
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Lexogen operates in Healthcare & Life Sciences and is based in Vienna. Its latest recorded funding round was a Grant round in April 2020.
Lexogen is a biotechnology company that develops and sells technologies and kits for RNA analysis and offers end-to-end Next-Generation Sequencing (NGS) services.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Hardware Sales, Government Contracts
AI Layer
Infrastructure
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Lexogen Comparables
Compare Lexogen with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Alithea Genomics | 83% | |
| SeqWell | 77% | |
| Danaher | 77% |
For institutional investors. Book with your work email.
Lexogen Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Apr 29, 2020 | ||||
| Grant | Jan 1, 2012 | ||||
| Accelerator | Aug 1, 2007 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Lexogen Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Austria Wirtschaftsservice | Seed |
| FFG Austrian Research Promotion Agency | Grant |
| INiTS | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 20, 2026
Open roles increased to 102, 170% of current headcount.
- Jan 26, 2026
Monthly visitors increased 31% MoM to 21.6K.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- partners_withOct 13, 2026
On Oct 13th '26 in Austria, Lexogen partners with Mithrl to connect RNA-Seq library preparation with AI-powered biological interpretation in one workflow, with four weeks of free access to Mithrl-1 included with every kit purchase.
For institutional investors. Book with your work email.
Lexogen Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Lexogen's valuation, stock price, and market status.
Is Lexogen a public or private company?
Lexogen is a private company.
What is the current stock price of Lexogen?
Lexogen is a private company, so its shares have no public market price. Caplight tracks Lexogen's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Lexogen worth (valuation)?
Valuation information for Lexogen is not publicly available.
Can I buy Lexogen stock?
Lexogen shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Lexogen's last funding round?
Lexogen's most recent funding round was Grant on April 29, 2020.
Who are the main investors in Lexogen?
Key investors in Lexogen include Austria Wirtschaftsservice.
Will Lexogen IPO soon?
No public IPO plans have been announced for Lexogen.
How can I track Lexogen secondary market activity?
Caplight tracks bids, offers, and trades in Lexogen's shares on secondary markets.